Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals

2019-04-03
Price :
Published : Apr-2019
No. of Pages : 87
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2019
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2019
2.2.1 Danaher to Acquire Biopharma Business from General Electric for USD21.4 Billion
2.2.2 Takeda Pharma Files Shelf Registration Statement for Public Offering of Hybrid Bonds Due 2079 for USD4.52 Billion
2.2.3 Roche to Acquire Spark Therapeutics
2.2.4 GlaxoSmithKline and Merck Enter into Co-Development Agreement
2.2.5 Abpro and Jiangsu Chia-tai Tianqing Pharma Enter into Development Agreement
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2019
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2019
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2019
3.1.1 Top M&A Deals in February 2019
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2018 - February 2019
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2019
3.2.1 Top Equity Offering Deals in February 2019
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2018 - February 2019
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2019
3.3.1 Top PE/VC Deals in February 2019
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2019
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2019
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-February 2019
3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-February 2019
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2019
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2018 - February 2019
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2019
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2019
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2018 - February 2019
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2018 - February 2019
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2019
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2019
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2019
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2018 - February 2019
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2018 - February 2019
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2018 - February 2019
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2018 - February 2019
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2019
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2019
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2019
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2019
5.1.1 Oncology - Deals of the Month
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2019
5.2.1 Central Nervous System - Deals of the Month
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2019
5.3.1 Infectious Diseases - Deals of the Month
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2019
5.4.1 Cardiovascular - Deals of the Month
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2019
5.5.1 Immunology - Deal of the Month
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, February 2019
5.6.1 Gastrointestinal - Deals of the Month
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, February 2019
5.7.1 Metabolic Disorders - Deals of the Month
6 Deal Summary by Geography
6.1 Pharmaceuticals & Healthcare, North America Deals, February 2019
6.1.1 North America - Deals of the Month
6.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2019
6.2.1 Europe - Deals of the Month
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2019
6.3.1 Asia-Pacific - Deals of the Month
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2019
6.4.1 Rest of the World - Deals of the Month
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2018 - February 2019
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2018 - February 2019
8 Further Information
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclosure information
8.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, February 2019
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), February 2019
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, February 2019
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2018 - February 2019
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, February 2019
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, February 2019
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, September 2018 - February 2019
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), February 2019
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2018 - February 2019
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), February 2019
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2018 - February 2019
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), September 2018 - February 2019
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), February 2019
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2018 - February 2019
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2019
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, February 2019
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, February 2019
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, February 2019
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), September 2018 - February 2019

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), February 2019
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), February 2019
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2018 - February 2019
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2018 - February 2019
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), February 2019
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), February 2019
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2018 - February 2019
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2018 - February 2019
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, September 2018 - February 2019
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), September 2018 - February 2019
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), February 2019
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), September 2018 - February 2019
Filed in: Pharmaceutical
Publisher : GlobalData